Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced biocatalytic dynamic kinetic resolution patent CN103820521B enables high-purity pharmaceutical intermediate manufacturing with substantial cost reduction and supply reliability.
Novel patent CN118541351A details mild pyrrole synthesis avoiding chiral resolution. Delivers high purity and supply chain reliability for pharmaceutical intermediate manufacturing globally.
Patent CN107828831B details a green enzymatic route for chiral tetrahydrofuran acids, offering cost reduction and high purity for pharmaceutical intermediate manufacturing.
Patent CN1900298A details a high-yield enzymatic route for D-tyrosine. Offers >99.5% ee and scalable production for pharma intermediates.
Patent CN106432199A details ultrasound resolution for ondansetron. Offers high purity and scalable manufacturing for reliable pharmaceutical intermediates supplier partnerships.
Patent CN101611026A details a safer enzymatic route for pyrrolidine dicarboxamide derivatives, offering cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN101952252A details a tartaric acid resolution method for high-purity piperidine intermediates, offering significant cost reduction in API manufacturing and supply chain reliability.
Patent CN1322200A details a scalable enantioselective synthesis for non-steroidal antiestrogen intermediates. Discover cost reduction in pharmaceutical manufacturing and supply chain advantages.
Analysis of patent CN109438431B reveals a high-yield L-menthol route for Lamivudine. Discover cost reduction in API manufacturing and supply chain reliability.
Novel sulfonamide-based synthesis for high-purity quinolone intermediates. Safe, scalable process reducing hazardous reagents for reliable pharmaceutical supply chains.
Patent CN108642119B details a lipase-catalyzed method for high-purity chiral intermediates, offering cost-effective and scalable manufacturing solutions.
Advanced resolution method for S-2-aminobutanamide hydrochloride improves yield and purity. Cost-effective levetiracetam intermediate manufacturing via mother liquor recycling.
Patent CN104945345B reveals a cost-effective synthesis route for chiral morpholine intermediates, offering significant supply chain stability and purity advantages for pharmaceutical manufacturing.
Patent CN117701649B reveals enzymatic DKR for Brivaracetam intermediates. Achieve 99% ee and reduced costs. Reliable pharmaceutical intermediate supplier for scale-up.
Patent CN110467539B reveals a cost-effective dynamic kinetic resolution for 2,6-dimethyl-L-tyrosine, eliminating noble metals and enhancing supply chain stability for peptide manufacturers.
Patent CN101679295A discloses novel hydantoins for enantiomerically pure amino acids, enabling cost-effective Ramipril and Perindopril manufacturing.
Patent CN107384980A reveals efficient Reformatsky and lipase resolution for beta-hydroxy-gamma-amino acids, offering cost reduction and supply reliability for pharma intermediates.
Novel patent CN106966912B enables efficient Dolutegravir intermediate production with high optical purity and scalable manufacturing processes for global supply chains.
Patent CN102381947B details a green 3-step synthesis for high-purity chiral 2,2'-dialkoxy-1,1'-binaphthyl, offering significant cost reduction and supply chain reliability.
Discover a novel asymmetric synthesis method for Sitagliptin base using L-DTTA. Eliminate noble metals and high-pressure hydrogenation for safer, scalable pharmaceutical manufacturing.